Home/Filings/4/0001209191-23-000957
4//SEC Filing

Nickson Philip 4

Accession 0001209191-23-000957

CIK 0001826457other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:31 PM ET

Size

5.5 KB

Accession

0001209191-23-000957

Insider Transaction Report

Form 4
Period: 2023-01-03
Nickson Philip
Chief Business & Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-03+123,650123,650 total
    Exercise: $7.78Exp: 2033-01-02Common Stock (123,650 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Monte Rosa Therapeutics, Inc.

CIK 0001826457

Entity typeother

Related Parties

1
  • filerCIK 0001911369

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:31 PM ET
Size
5.5 KB